Guangzhou Sino-Israel Bio-Industry Investment Fund Overview

  • Investor Type
  • Venture Capital

  • Status
  • Active

  • Professionals
  • 6

Professionals

  • Investments
  • 20

  • Portfolio
  • 12

  • Exits
  • 5

Exits

Guangzhou Sino-Israel Bio-Industry Investment Fund General Information

Company Description

Founded in 2015, Guangzhou Sino-Israel Bio-Industry Investment Fund is a Chinese biotech and pharmaceutical venture capital fund based in Guangzhou, China. The fund focuses on the Chinese market and invests in clinical-stage companies, including programs approaching First-in-Human (FIH) development within 6-9 months. The fund primarily invests in international biotech and pharmaceutical companies seeking to enter the Chinese market. Its investment model involves the establishment of joint ventures in which the parent company retains majority ownership and the fund holds a minority position. GIBF Fund III, scheduled to launch in 2027, will expand the investment strategy to include Chinese companies. The fund provides financing and support related to patient recruitment, participation in the local biotech ecosystem, and navigation of the National Medical Products Administration (NMPA) regulatory process.

Business Details

Website
www.gibf-bio.com
Year Founded
2015
Investor Status
Actively Seeking New Investments
Primary Investor Type
Venture Capital
Corporate Office
  • 2nd Floor Building 1
  • Unit 3, Guangzhou International Bio-Island
  • Guangzhou, Guangdong
  • China
+86 020

Guangzhou Sino-Israel Bio-Industry Investment Fund Investments (20)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Oncology Acceleration Venture (Biond Biologics / Guangzhou-Israel Biotechnology Fund) 01-Jun-2026 Joint Venture Biotechnology Generating Revenue
Ruibaiwei Pharmaceutical 18-Sep-2024 Biotechnology Startup
BioVersys 11-Sep-2024 Drug Discovery Generating Revenue
Nectin Therapeutics 06-May-2024 Biotechnology Pre-Clinical Trials
Naketin Pharmaceutical 21-Nov-2023 Biotechnology Startup
Orvida Pharma 19-Sep-2022 Drug Discovery Clinical Trials - Phase 1
Nectin Therapeutics 23-Feb-2022 Biotechnology Pre-Clinical Trials
Modular Surgical 17-Oct-2021 Surgical Devices Generating Revenue
CoreBone 04-Oct-2021 Later Stage VC Other Devices and Supplies Generating Revenue
CorNeat Vision 25-Aug-2021 Later Stage VC Therapeutic Devices Product Development
You’re viewing 10 of 20 investments. Get the full list »

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Guangzhou Sino-Israel Bio-Industry Investment Fund Exits (5)

Company Name Exit Date Exit Type Exit Size
Alpha Omega Engineering 01-Aug-2026 Secondary Transaction - Private
Visionix (Diagnostic Equipment) 28-May-2026
BioVersys 07-Feb-2025
Silexion Therapeutics 15-Aug-2024 Reverse Merger
InMode 08-Aug-2019 IPO
To view Guangzhou Sino-Israel Bio-Industry Investment Fund’s complete exits history, request access »

Guangzhou Sino-Israel Bio-Industry Investment Fund Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

Guangzhou Sino-Israel Bio-Industry Investment Fund Co-Investors (11)

Name With Exits Lead Partner Series Industry
GSK 1 Series chart Industry bar
IFB Group Series chart Industry bar
Israel Biotech Fund Series chart Industry bar
Marius Nacht Series chart Industry bar
Peregrine Ventures Series chart Industry bar
You’re viewing 5 of 11 co-investors. Get the full list »

Guangzhou Sino-Israel Bio-Industry Investment Fund FAQs

  • What is Guangzhou Sino-Israel Bio-Industry Investment Fund?

    Founded in 2015, Guangzhou Sino-Israel Bio-Industry Investment Fund is a Chinese biotech and pharmaceutical venture capital fund based in Guangzhou, China.

  • When was Guangzhou Sino-Israel Bio-Industry Investment Fund founded?

    Guangzhou Sino-Israel Bio-Industry Investment Fund was founded in 2015.

  • Where is Guangzhou Sino-Israel Bio-Industry Investment Fund headquartered?

    Guangzhou Sino-Israel Bio-Industry Investment Fund is headquartered in Guangzhou, China.

  • What is Guangzhou Sino-Israel Bio-Industry Investment Fund's total asset value?

    Guangzhou Sino-Israel Bio-Industry Investment Fund has around in total assets under management.

  • How many investments has Guangzhou Sino-Israel Bio-Industry Investment Fund made?

    Guangzhou Sino-Israel Bio-Industry Investment Fund has made 20 investments.

  • What has Guangzhou Sino-Israel Bio-Industry Investment Fund invested in?

    Guangzhou Sino-Israel Bio-Industry Investment Fund has made numerous investments in companies like Oncology Acceleration Venture (Biond Biologics / Guangzhou-Israel Biotechnology Fund), Ruibaiwei Pharmaceutical, and BioVersys within the Biotechnology and Drug Discovery industries.

  • What has Guangzhou Sino-Israel Bio-Industry Investment Fund invested in recently?

    Guangzhou Sino-Israel Bio-Industry Investment Fund's latest investment was on 01-Jun-2026 in Oncology Acceleration Venture (Biond Biologics / Guangzhou-Israel Biotechnology Fund), a company within the Biotechnology industry.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process